FIGURE

Fig. 4

ID

ZDB-FIG-200402-4

Publication

Ma et al., 2019 - A Comprehensive Study of High Cholesterol Diet-Induced Larval Zebrafish Model: A Short-Time In Vivo Screening Method for Non-Alcoholic Fatty Liver Disease Drugs

Other Figures

All Figure Page

Back to All Figure Page

Fig. 4

Evaluation of HCD induced larval zebrafish models by bezafibrate and pioglitazone treatments. (A) Experimental outline of NAFLD larval zebrafish with BZT and PIO administration groups. (B) Survival rate of larval zebrafish (n=3). (C) weight changes of larval zebrafish (D) Width changes of larval zebrafish. (E)TC level of larval zebrafish (n=6). (F) TG level of larval zebrafish (n=6). Bar indicate means ± SD. n.s.P >0.05, *P <0.05, **P <0.01, ***P<0.001 represent significance of difference, P<0.05 was considered as statistically significant. Significant was calculated by ANOVA followed by turkey's test. n indicates the replicates of experiment.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	WT
Conditions:	chemical treatment: bezafibrate, chemical treatment by diet: cholesterol chemical treatment by diet: cholesterol chemical treatment: pioglitazone, chemical treatment by diet: cholesterol
Observed In:	trunk whole organism whole organism cholesterol whole organism triglyceride
Stage Range:	Days 7-13 to Days 21-29

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Biol. Sci.